| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytomx Therapeutics, Inc. (CTMX) have been net sellers, shedding 1,624 shares worth roughly $5K on balance.
CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 987.9K | $3.42M | - | |
| Other | 650.0K | $2.25M | - | |
| CFO | 295.3K | $1.02M | - | |
| Other | 100.0K | $346.0K | - | |
| Other | 87.5K | $302.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2017 | Tepper Robert I | 10% Owner | Sell | 24,777 | $24.34 | $603,072.18 | -45.6% | |
| Oct 4, 2017 | Gluck Frederick W | Director | Sell | 10,000 | $24.27 | $242,680.00 | -3.1% | |
| Oct 2, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $18.10 | $45,250.00 | -14.6% | |
| Oct 2, 2017 | McCarthy Sean A.67 | President And CEO | Sale+OE | 9,562 | $18.57 | $177,566.34 | -69.3% | |
| Sep 26, 2017 | Gluck Frederick W | Director | Sell | 5,000 | $17.30 | $86,476.00 | -1.5% | |
| Sep 19, 2017 | Tepper Robert I | 10% Owner | Sell | 20,000 | $18.00 | $360,000.00 | -26.9% | |
| Sep 1, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $17.17 | $42,925.00 | -12.7% | |
| Sep 1, 2017 | McCarthy Sean A.67 | President And CEO | Sale+OE | 9,930 | $17.32 | $171,987.60 | -70.1% | |
| Aug 31, 2017 | McCarthy Sean A.67 | President And CEO | Sale+OE | 18,756 | $17.50 | $328,260.00 | -62.0% | |
| Aug 9, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $15.00 | $37,500.00 | -11.3% |